| 57 |
increased |
cell death
(GO:0008219)
|
|
2 Events
|
| 50 |
occurrence |
membrane depolarization
(GO:0051899)
|
|
616: Occurrence, A paroxysmal depolarizing shift
|
| 44 |
abnormal |
chemical synaptic transmission
(GO:0007268)
|
|
None
|
| 64 |
decreased |
memory
(GO:0007613)
|
|
341: Impairment, Learning and memory
|
| 31 |
decreased |
weight loss
(MP:0001263)
|
|
None
|
| 28 |
abnormal |
abnormal lipid homeostasis
(MP:0002118)
|
|
862: Not Increased, Circulating Ketone Bodies
|
| 21 |
decreased |
excitatory postsynaptic potential
(GO:0060079)
|
|
1268: Decrease, Excitatory postsynaptic potential
|
| 59 |
decreased |
learning
(GO:0007612)
|
|
341: Impairment, Learning and memory
|
| 58 |
increased |
neurodegeneration
(MP:0002229)
|
|
352: N/A, Neurodegeneration
|
| 67 |
decreased |
cytokine production involved in inflammatory response
(GO:0002534)
|
|
152: Suppression, Inflammatory cytokines
|
| 51 |
decreased |
chemical synaptic transmission
(GO:0007268)
|
|
669: Reduction, Neuronal synaptic inhibition
|
| 16 |
increased |
mortality
(MESH:D009026)
|
|
4 Events
|
| 15 |
increased |
muscle contraction
(GO:0006936)
|
|
2 Events
|
| 1 |
increased |
cell proliferation
(GO:0008283)
|
|
3 Events
|
| 13 |
decreased |
ecdysis-triggering hormone activity
(GO:0008255)
|
|
988: Decrease, Circulating ecdysis triggering hormone
|
| 52 |
occurrence |
excitatory postsynaptic potential
(GO:0060079)
|
|
682: Generation, Amplified excitatory postsynaptic potential (EPSP)
|
| 36 |
disrupted |
ovulation cycle
(GO:0042698)
|
|
None
|
| 10 |
increased |
loss of dopaminergic neurons
(MP:0003244)
|
|
890: Degeneration of dopaminergic neurons of the nigrostriatal pathway
|
| 63 |
decreased |
synaptic signaling
(GO:0099536)
|
|
2 Events
|
| 45 |
increased |
cochlear degeneration
(MP:0000032)
|
|
319: Loss, Cochlear function
|
| 27 |
decreased |
ketosis
(MESH:D007662)
|
|
2 Events
|
| 53 |
occurrence |
seizures
(NBO:0000025)
|
|
613: Occurrence, Epileptic seizure
|
| 35 |
decreased |
fertility
(MESH:D005298)
|
|
406: decreased, Fertility
|
| 3 |
increased |
hepatocellular carcinoma
(MESH:D006528)
|
|
334: Promotion, Hepatocelluar carcinoma
|
| 2 |
increased |
hyperplasia
(MESH:D006965)
|
|
3 Events
|